Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TCDA

Tricida (TCDA) Stock Price, News & Analysis

Tricida logo

About Tricida Stock (NASDAQ:TCDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.19
52-Week Range
N/A
Volume
31.13 million shs
Average Volume
17.62 million shs
Market Capitalization
$6.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TCDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter.

TCDA Stock News Headlines

Patrick G Enright's Net Worth
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Tricida Inc (TCDAQ)
Firm Retention Summary: Tricida Inc.
Tricida Announces Third Quarter 2022 Financial Results
Tricida Provides Strategic Update
See More Headlines

TCDA Stock Analysis - Frequently Asked Questions

Tricida, Inc. (NASDAQ:TCDA) announced its quarterly earnings results on Monday, November, 8th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09.

Tricida (TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tricida investors own include Sorrento Therapeutics (SRNE), Alibaba Group (BABA), NIO (NIO), Pfizer (PFE), Energy Transfer (ET), Teladoc Health (TDOC) and Sesen Bio (SESN).

Company Calendar

Last Earnings
11/08/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TCDA
CIK
1595585
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$176.57 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-103.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.87
Quick Ratio
4.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
55,670,000
Free Float
35,851,000
Market Cap
$6.01 million
Optionable
Not Optionable
Beta
0.22
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:TCDA) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners